$TRUP

Tooth Margaret sold $11K of TRUP

Tooth Margaret (CEO) sold 491 shares of TRUPANION, INC. (TRUP) at $21.86 on 2026-05-25.

Original reporting
SEC EDGAR · Tooth Margaret
Published May 28, 2026, 1:41 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 28, 2026, 2:03 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$TRUP
Neutral
medium confidence
Mentioned
$TRUP
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TRUPNeutralLow
01

Why it matters

This is an ownership-change event: the CEO executed an open-market sale of 491 shares at a stated price, which may briefly affect sentiment but does not provide new operational or financial information.

02

Market read

Traders may monitor insider-flow for sentiment, but absent a fundamental catalyst, expected price reaction is typically muted.

03

What to watch

No 10b5-1 plan is cited, but the filing alone doesn’t reveal intent; without follow-on filings or operational news, trading impact should be discounted.

Relevance 6/10Timing: Immediate (today/next session) as traders may react to insider-flow headlines; otherwise low follow-through risk.

Background

The article is an SEC Form 4 insider transaction disclosure for TRUPANION, INC. (TRUP).

Company-level read

Ticker impact

$TRUPNeutralMedium confidence
Context

TRUP CEO sold 491 shares in an open-market transaction at $21.86 on 2026-05-25, disclosed via SEC Form 4.

Expected impact

Likely limited, short-lived impact; any move would be more sentiment-driven than thesis-driven.

Evidence & confidence

The filing is an officer/director open-market sale with no 10b5-1 plan stated, but the article provides no accompanying company-specific catalyst (earnings, guidance, deal, or litigation).

Market effects

Minimal; this is company-specific insider activity without sector-wide information.

None indicated.

None indicated.

Counterpoint

The sale could be routine liquidity/portfolio management rather than a negative view, especially given the small share count relative to holdings.

Key entities

  • TRUPANION, INC.

    Company whose CEO reported an open-market sale of 491 shares via SEC Form 4.

  • Tooth Margaret

    CEO/officer/director who sold shares; filing includes post-transaction holdings.

Related articles

$METMed

Financial results round-up: MetLife, Prudential, Corebridge, Palomar, Heritage, TWFG, Root and more

A financial results roundup covers multiple insurers and MGAs. MetLife reported Q2 net income of $705m and adjusted EPS $2.43. Prudential posted Q2 net income of $985m and record individual life sales. Corebridge reported a $16m net loss and merger approval. Palomar, Heritage, TWFG, Root, Trupanion and Clover Health also reported Q2 figures and guidance updates.

$TRUPMed

TRUPANION, INC. (TRUP): Results of Operations and Financial Condition

TRUPANION, INC. (TRUP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex991q22026.htm EX-99.1 Document Exhibit 99.1 Trupanion Reports Second Quarter 2026 Results Authorizes Share Repurchase Program SEATTLE, WA. August 5, 2026 -- Trupanion , Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced fin